Researchers to test "wash" method for blood transfusions in babies | FDA OKs first seasonal flu vaccine made using animal cell cultures | Researchers look for causes of follicular lymphoma
Web Version
 
 
November 26, 2012
AABB SmartBrief
News for the transfusion medicine and cellular therapy community
SIGN UP|FORWARD|ARCHIVE

Top StorySponsored By
Researchers to test "wash" method for blood transfusions in babies
Australian researchers are preparing to conduct a two-year study of the use of a "blood-washing" method before transfusions for premature infants. The researchers want to find out whether the technique can reduce inflammation and other complications linked to transfusions. The study will examine the washing method against current best practices for the transfusion of packed red blood cells. News.com.au (Australia)/The Advertiser (Adelaide, Australia) (11/22)
Share: LinkedInTwitterFacebookGoogle+Email
Announcing the Arrival of FMH RapidScreen from Immucor
The new FMH RapidScreen offers a faster more simplified feto-maternal hemorrhage screening test to give you peace of mind in generating a quick result for the protection of mothers and their newborns. FMH RapidScreen provides up to 35% decrease in total test time compared to other marketed tests. To learn more about this product, call us at 855-IMMUCOR or visit our website.
Advertisement
 
Science & Health
FDA OKs first seasonal flu vaccine made using animal cell cultures
The FDA has approved the use of Novartis' seasonal influenza vaccine for people ages 18 and older. The vaccine, which will be marketed under the brand name Flucelvax, is the first seasonal flu vaccine produced using animal cell cultures instead of the traditional chicken egg method, which allows for a faster production process. Reuters (11/20)
Share: LinkedInTwitterFacebookGoogle+Email
Researchers look for causes of follicular lymphoma
Researchers at the University of New South Wales in Australia are preparing to undertake a study that will look into the causes of follicular lymphoma. The study will involve people with the disease and their relatives without it and will explore DNA, lifestyles and employment. The Australian (tiered subscription model)/Australian Associated Press (11/21)
Share: LinkedInTwitterFacebookGoogle+Email
Researchers in Greece use advanced techniques in blood research
Researchers in Athens, Greece, are using advanced devices such as the atomic force microscope and scanning electron microscope to study blood samples from patients with kidney and autoimmune diseases. The researchers are looking specifically at changes in human blood following the infusion of artificial plasma. Greek Reporter blog (11/20)
Share: LinkedInTwitterFacebookGoogle+Email
Discount on Regenerative Medicine Journal offered to AABB members
AABB has partnered with Regenerative Medicine Journal to offer a six-issue online subscription for $30 to AABB members. This journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine. Visit the AABB Marketplace or add-on to your online AABB membership renewal.
Advertisement
 
Hot Topics
Emerging Trends
CMS selects 3 groups to participate in data sharing initiative
CMS has selected the Kansas City Quality Improvement Consortium, the Health Improvement Collaborative of Greater Cincinnati and the Oregon Health Care Quality Corp. to be the first groups to participate in the agency's Medicare data sharing initiative. The data exchange program offers HHS-certified organizations Medicare claims information, which can be used to assess the performance of providers. Modern Healthcare (subscription required) (11/21)
Share: LinkedInTwitterFacebookGoogle+Email
Industry News & Practice
Kiadis pulls in close to $13M for trial of cell-based treatment
Kiadis Pharma secured about $13 million in financing from new and existing investors. Proceeds will go toward a midstage trial and a Phase II/III trial of the firm's ATIR, an investigational cell-based treatment designed to permit stem cell transplantations for blood cancer patients with mismatched family donors. Pharmaceutical Business Review Online (11/21)
Share: LinkedInTwitterFacebookGoogle+Email
Mass. allows drug sharing among hospitals facing shortages
The Massachusetts Department of Public Health adopted emergency rules letting hospitals share drugs to deal with shortages caused by the closure of the New England Compounding Center and its sister company Ameridose after a nationwide meningitis outbreak. Although the change won't address long-term problems, it is "a significant and positive step toward easing the medication shortage," the Massachusetts Hospital Association said. The Boston Globe (tiered subscription model)/White Coat Notes blog (11/21)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
HeartWare gains FDA approval for cardiac pump
HeartWare has obtained approval from the FDA for its left ventricular assist device, a cardiac pump designed to aid blood flow in end-stage heart failure patients awaiting transplants. The lifesaving benefits of the system have been shown in a clinical study to outweigh the risks, according to the FDA. Reuters (11/20)
Share: LinkedInTwitterFacebookGoogle+Email
ONC envisions 1,000 rural hospitals achieving MU in 2 years
The Office of the National Coordinator for Health IT aims to have 1,000 rural hospitals demonstrating meaningful use of health IT by the close of 2014. To encourage sharing of best practices and accelerate HIT adoption, the agency has set up the Rural Community of Practice to oversee pilot programs, with subcommittees to track the key issues faced by rural hospitals. Healthcare Informatics online (11/20)
Share: LinkedInTwitterFacebookGoogle+Email
Association News
AABB seeks next CEO
AABB seeks a leader with a commitment to improving health care to serve as its next chief executive officer. This prestigious position offers an extraordinary opportunity to lead a respected national professional and scientific association that serves as a preeminent knowledge-based organization focused on improving health through advancing the science and practice of transfusion medicine and cellular therapies. The executive search firm Witt/Kieffer has been retained by AABB to assist in recruiting the new CEO. Those interested in applying for the position should visit the company's website for more details.
Share: LinkedInTwitterFacebookGoogle+Email
Who's Hiring?
Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Help Desk SpecialistAABBUS - MD
Click here to view more job listings.
 
SmartQuote
The passion for setting people right is in itself an afflictive disease."
-- Marianne Moore,
American poet and writer
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AABB® ->Homepage | Join AABB | Conferences | Marketplace | AABB CareerLink
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tom Parks
Managing Editor:  Amanda Horn
Advertising Manager:  Annette Bacchus
  M: 240.333.6604
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information